Yamaguchi T
Center for Cardiovascular Disease, Mitsui Memorial Hospital, Tokyo.
J Cardiol. 1987 Sep;17(3):643-52.
To elucidate the current use of percutaneous transluminal coronary angioplasty (PTCA) in Japan, questionnaires concerning PTCA experience in 1986 and indications for using PTCA were sent to 53 relatively experienced centers. The results were collected from 46 centers (87%), and the data were analyzed. A total of 5,255 PTCA were performed in 1986, which was 35% greater than that in 1985. Of these, 4,440 PTCA procedures were performed in patients with angina. Primary success was achieved in 3,790 patients (85%), and complications included 21 deaths (0.5%), 41 emergency bypass surgery (CABG) (0.9%), and 118 myocardial infarction (MI) (2.7%). Another 815 PTCA procedures were performed in patients with acute myocardial infarction, of which 58% were direct PTCA and 42% were PTCA following thrombolysis. Primary success was achieved in 674 patients (83%) with complications of deaths in 19 (2.3%) and emergency CABG in 17 (2.1%). The initial treatments in patients with significant coronary stenosis diagnosed by initial coronary arteriography in 1986 were analyzed. In 6,845 patients with angina or old myocardial infarction, medical treatment was selected in 46%, PTCA in 40% and CABG in 14%. In 1,506 patients with acute infarction, medical treatment was performed in 21%, PTCA including PTCA following thrombolysis in 44%, CABG in 3% and only coronary thrombolysis in 32%. Questions on criteria required to select patients for PTCA and clinical or angiographic indications for PTCA were also asked. The following conditions were not necessarily required in more than half of the centers: symptoms, refractoriness to medical treatment and surgical candidates. However, evidence of myocardial ischemia and viability of the lesion-related myocardium were required as criteria in the majority of centers. The following clinical or angiographic features were not always indicated in more than two-third of centers: i.e. cardiogenic shock, and 90% or less stenosis in acute infarction, 75% stenosis in variant angina, patients over 80 years old, poor cardiac function with 29% or less ejection fraction, severely calcified coronary lesions, long segment lesions (greater than or equal to 2 cm), distal lesions, unprotected left main trunk lesions, total obstructions (of more than three months duration), and three vessel disease with two total occlusions and one discrete lesion.
为阐明经皮腔内冠状动脉成形术(PTCA)在日本的当前应用情况,向53个经验相对丰富的中心发送了关于1986年PTCA经验及PTCA使用指征的调查问卷。从46个中心(87%)收集到了结果,并对数据进行了分析。1986年共进行了5255例PTCA,比1985年增加了35%。其中,4440例PTCA手术是针对心绞痛患者进行的。3790例患者(85%)获得了初步成功,并发症包括21例死亡(0.5%)、41例急诊冠状动脉搭桥术(CABG)(0.9%)和118例心肌梗死(MI)(2.7%)。另外815例PTCA手术是针对急性心肌梗死患者进行的,其中58%为直接PTCA,42%为溶栓后PTCA。674例患者(83%)获得了初步成功,并发症包括19例死亡(2.3%)和17例急诊CABG(2.1%)。对1986年初次冠状动脉造影诊断为严重冠状动脉狭窄患者的初始治疗情况进行了分析。在6845例心绞痛或陈旧性心肌梗死患者中,46%选择了药物治疗,40%选择了PTCA,14%选择了CABG。在1506例急性心肌梗死患者中,21%进行了药物治疗,44%进行了PTCA(包括溶栓后PTCA),3%进行了CABG,32%仅进行了冠状动脉溶栓。还询问了选择PTCA患者所需的标准以及PTCA的临床或血管造影指征等问题。超过半数的中心不一定要求以下条件:症状、对药物治疗无效以及适合手术。然而,大多数中心要求有心肌缺血的证据以及病变相关心肌的存活情况作为标准。超过三分之二的中心并不总是将以下临床或血管造影特征作为指征:即心源性休克、急性心肌梗死时狭窄90%或以下、变异型心绞痛时狭窄75%、80岁以上患者、射血分数29%或以下的心脏功能不佳、冠状动脉严重钙化病变、长节段病变(大于或等于2厘米)、远端病变、无保护的左主干病变、完全闭塞(持续时间超过三个月)以及三支血管病变合并两处完全闭塞和一处孤立病变。